Michael K. Hehir

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Immediate versus deferred treatment for advanced prostatic cancer: Initial results of the Medical Research Council trial

Reza Adib, John Anderson, M Handley Ashken et al. · Kent Academic Repository (University of Kent) · 1997 · 552 citations

Immediate Versus, Urology, Surgical Oncology +13

Rituximab as treatment for anti-MuSK myasthenia gravis

Michael K. Hehir, Lisa D. Hobson‐Webb, Michael Benatar et al. · Neurology · 2017 · 243 citations

Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

Saiju Jacob, Srikanth Muppidi, Amanda C. Guidon et al. · Journal of the Neurological Sciences · 2020 · 154 citations · Full text

Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial

Michael Benatar, Michael McDermott, Donald B. Sanders et al. · Muscle & Nerve · 2015 · 139 citations · Full text